![]() |
市场调查报告书
商品编码
1890751
齐墩果酸市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2024-2032)Oleanolic Acid Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
受医药、营养补充品、化妆品和功能性食品领域对天然生物活性化合物需求不断增长的推动,全球齐墩果酸市场持续稳定成长。根据最新产业数据,2023年该市场规模预计为2,750万美元,预计2024年将达到2,800万美元,主要得益于其在肝臟健康维护、抗发炎治疗和含抗氧化剂产品等领域的应用不断扩展。到2029年,该市场预计将达到3,480万美元,2024年至2029年的复合年增长率(CAGR)为5.6%。展望2032年,由于全球对植物性治疗化合物的需求不断增长,预计该市场将继续扩张。
预计2023年,中国将继续引领市场,占74.22%的市场。这得益于中国在中医药领域强大的应用基础、成熟的提取产业以及对高品质天然化妆品日益增长的需求。陕西嘉禾植物化学、Focusherb、四川宇鑫药业、Sabinsa和四川贝纳普药业等主要生产商在为医药和护肤品配方提供高纯度齐墩果酸方面保持领先地位。
市场驱动因素
医药产业仍是主要的成长推动力。齐墩果酸具有显着的保肝、抗发炎、抗癌和抗糖尿病作用,使其成为现代和传统医学中重要的生物活性成分。随着非酒精性脂肪肝 (NAFLD)、肝炎和药物性肝损伤等肝臟疾病在全球范围内的日益普遍,基于齐墩果酸的保肝药物研发投入持续增长。
此外,肿瘤学研究正在探索其抑制肿瘤进展和诱导细胞凋亡的潜力,从而推动其在实验性癌症治疗中的应用。随着消费者越来越倾向于天然和植物性药物,製药公司正在将齐墩果酸添加到现代配方中,以满足这种不断增长的需求。
市场限制因子
供应链不稳定,特别是对农业原料的依赖,是一个主要挑战。季节性波动、植物产量波动和纯度差异都会影响生产成本和供应可靠性。製药、营养保健品和化妆品行业的监管复杂性也限制了市场扩张,因为每个行业都需要不同的安全文件和批准流程。
与其他天然成分(例如姜黄素和白藜芦醇)相比,消费者对齐墩果酸的认知度仍然相对较低,这减缓了其在大众市场健康和美容产品中的普及。此外,不同供应商之间的纯度差异也为需要稳定活性成分含量的製造商带来了标准化方面的挑战。
市场机会
消费者对天然护肤和抗衰老产品的需求不断增长,这为市场带来了巨大的成长机会。齐墩果酸具有抗氧化、抗菌、调节皮脂分泌和抗皱的特性,使其成为高端护肤品配方中的理想成分。随着全球消费者寻求成分纯净、植物性的化妆品,齐墩果酸在精华液、乳霜、乳液和抗痘产品中越来越受到关注。
其多功能性也使其在营养保健品、功能性食品和健康补充剂中的应用不断拓展,以支持免疫功能、代谢健康和肝臟功能。随着临床研究的进展,预计到 2032 年,新的治疗应用将进一步推动市场成长。
市场趋势
影响市场发展的关键趋势是齐墩果酸越来越多地应用于製药和个人护理创新产品。随着研究发现其新的治疗特性,人们对高纯度产品(例如 95% 和 98%)的兴趣日益浓厚。消费者对环保植物配方产品的需求日益增长,加速了天然化妆品产业的普及;同时,消费者对草本护肝疗法的需求也推动了营养保健品产业的成长。
虽然新冠疫情初期扰乱了采购和生产,但从长远来看,随着消费者转向天然保健品,需求反而增强了。
依类型划分, "其他" (主要为98%纯度)预计将在2023年占市场主导地位,这主要得益于其在医药级配方和高端护肤品中的高应用。 95%纯度细分市场预计也将强劲成长,这得益于消费者对高效天然保健品和高纯度医药原料的需求。
依应用领域划分,医药产业在2023年占最大占有率,这主要得益于其在肝病、癌症和代谢性疾病治疗方面的应用。由于人们对增强免疫力和抗氧化功效的功能性食品的兴趣日益浓厚,健康食品行业预计将快速扩张。护肤品和化妆品(归类为 "其他" )也仍然是一个快速成长的应用类别。
预计到2023年,中国将以2,041万美元的市场规模引领全球市场,这主要得益于其与传统中医药的紧密结合、大规模的生产能力以及对天然化妆品需求的激增。
由于消费者越来越倾向于在药品、膳食补充剂和护肤品中使用天然和可持续成分,欧洲市场呈现强劲增长。美国市场则因人们对肝病、糖尿病和发炎等疾病的天然疗法日益关注而不断扩张。由于阿育吠陀医学的日益普及和生活方式相关疾病的增加,印度展现出巨大的市场潜力。
The global oleanolic acid market continues to grow steadily, supported by increasing demand for natural bioactive compounds in pharmaceuticals, nutraceuticals, cosmetics, and functional foods. According to the latest industry data, the market was valued at USD 27.5 million in 2023 and is projected to reach USD 28.0 million in 2024, driven by growing applications in liver health, anti-inflammatory therapies, and antioxidant formulations. By 2029, the market is expected to reach USD 34.8 million, reflecting a CAGR of 5.6% from 2024-2029. Extending the trajectory toward 2032, the market is poised for continued expansion as global preference for plant-based therapeutic compounds accelerates.
China continued to dominate the market landscape in 2023 with a 74.22% share, supported by strong Traditional Chinese Medicine (TCM) usage, established extraction industries, and rising demand for premium natural cosmetics. Major producers-including Shaanxi Jiahe Phytochem, Focusherb, Sichuan Yuxin Pharmaceutical, Sabinsa, and Sichuan Benepure Pharmaceutical-maintain a leading role in supplying high-purity oleanolic acid for pharmaceutical and skincare formulations.
Market Drivers
The pharmaceutical industry remains the leading growth driver. Oleanolic acid exhibits strong hepatoprotective, anti-inflammatory, anticancer, and antidiabetic properties, making it a valuable bioactive ingredient in modern and traditional medicine. With the rising global prevalence of liver diseases-including NAFLD, hepatitis, and drug-induced liver injury-research investment continues to increase for developing liver-protective drugs based on oleanolic acid.
Additionally, oncology research is exploring the compound's potential in inhibiting tumor progression and inducing apoptosis, fueling its use in experimental cancer therapeutics. As consumers increasingly shift toward natural and plant-derived medicines, pharmaceutical companies are integrating oleanolic acid into modern formulations to meet this growing demand.
Market Restraints
Supply chain instability, particularly dependence on agricultural raw materials, poses a key challenge. Seasonal variations, fluctuating plant yields, and inconsistent purity affect production costs and supply reliability. Regulatory complexities across pharmaceutical, nutraceutical, and cosmetic sectors also limit market expansion, as each requires different safety documentation and approval pathways.
Consumer awareness remains relatively low compared with other natural ingredients such as curcumin or resveratrol, slowing adoption in mass-market health and beauty products. Additionally, purity variations across suppliers create standardization challenges for manufacturers relying on consistent active ingredient levels.
Market Opportunities
The rising demand for natural skincare and anti-aging products offers major growth opportunities. The compound's antioxidant, antibacterial, sebum-regulating, and anti-wrinkle properties make it ideal for premium skincare formulations. As global consumers increasingly seek clean-label, plant-based cosmetic solutions, oleanolic acid is gaining attention in serums, creams, lotions, and anti-acne formulations.
Its versatility also supports its growing integration in nutraceuticals, functional foods, and health supplements targeting immunity, metabolic health, and liver function. As clinical research continues to expand, new therapeutic applications are expected to strengthen market growth through 2032.
Market Trends
A major trend shaping the market is the increasing integration of oleanolic acid into pharmaceutical and personal care innovations. Research continues to uncover new therapeutic properties, spurring interest in high-purity forms such as 95% and 98% concentrations. Rising consumer preference for eco-friendly, plant-derived formulations is accelerating adoption in natural cosmetics, while demand for herbal, hepatoprotective remedies supports growth in the nutraceutical sector.
COVID-19 initially disrupted sourcing and production but ultimately strengthened long-term demand, as consumers pivoted toward natural health-enhancing supplements.
By Type, the Others category (primarily 98% purity) dominated the market in 2023 due to high usage in pharmaceutical-grade formulations and luxury skincare. The 95% purity segment is also set for strong growth, supported by demand for potent natural supplements and near-pure pharmaceutical ingredients.
By Application, the pharmaceutical sector held the largest share in 2023, driven by its therapeutic use in liver disease, cancer, and metabolic disorders. The health food segment is expected to expand rapidly due to rising interest in functional foods promoting immunity and antioxidant benefits. Skincare and cosmetics, classified under the Others segment, remain a fast-growing application category.
China leads the global market with USD 20.41 million in 2023, supported by strong TCM integration, large-scale manufacturing capacity, and booming demand for natural cosmetics.
Europe exhibits strong growth driven by high consumer preference for natural, sustainable ingredients in pharmaceuticals, food supplements, and skincare. The U.S. market is expanding due to rising interest in natural treatments for liver disease, diabetes, and inflammation. India shows significant potential, supported by Ayurvedic practices and increasing prevalence of lifestyle-related diseases.
Conclusion
With the market increasing from USD 28.0 million in 2024 and projected toward continued growth through 2032, the oleanolic acid industry is positioned for strong long-term expansion. Rising demand for natural therapeutics, premium skincare, and plant-based health products will continue to push market development in the coming years.
Segmentation By Type, By Application, By Region
By Type * 30% Oleanolic Acid
By Application * Pharma
By Region * U.S.